Zobrazeno 1 - 10
of 69
pro vyhledávání: '"J C, Aldigier"'
Autor:
Ulrich Beyer, Francesco Locatelli, R. Schmidt, Frank C. Dougherty, Władysław Sułowicz, J.-C. Aldigier, D. Sanz Guajardo, Johannes F.E. Mann, B. Van Vlem
Publikováno v:
Scopus-Elsevier
BACKGROUND C.E.R.A., a continuous erythropoietin receptor activator, is a long-acting erythropoiesis-stimulating agent (ESA) that is approved for the treatment of renal anemia. This analysis evaluated the safety profile of C.E.R.A. in comparison to t
Publikováno v:
Science & Sports. 7:77-83
Resume En vue d'etudier les reponses hormonales des systemes vasoconstricteur et antinatriuretique ainsi que vasodilatateur et natriuretique au cours d'un effort intense, huit volontaires sains ont ete soumis a un exercice physique constitute de troi
Publikováno v:
Annales de Dermatologie et de Vénéréologie. 141:S458
Introduction Si les dermatophyties superficielles sont bien connues des dermatologues, les formes profondes localisees ou cutaneoviscerales, sont rarement rapportees. Nous decrivons une observation didactique de granulomes dermatophytiques cutanes pr
Publikováno v:
Journal of hypertension. 18(1)
Several experimental and clinical studies indicate that the renin system may play a pivotal role in progressing renal disease. The combination of an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker could provide a higher de
M-CSF serous rate evolution during post-transplantation days in a heterotopic heart graft model mice
Publikováno v:
The Journal of cardiovascular surgery. 38(6)
On heterotopic heart graft in mice, aged 7 weeks (C3H and B57), we investigate the variations of Macrophage Colony stimulating factor serous rate. The macrophage colony stimulating factor (M-CSF) is a cytokine involved in the immune response during t
Publikováno v:
Scopus-Elsevier
Acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) is a physiological inhibitor of the proliferation of haematopoietic stem cells. In 12 healthy volunteers treated with the angiotensin-converting enzyme (ACE) inhibitor enalapril (20mg day -1 for 15 days), we studied
Autor:
Y, Denizot, F, Rougier, F, Dupuis, C, Verger, C, Dulery, M, Laskar, J C, Aldigier, V, Praloran
Publikováno v:
Experimental hematology. 24(11)
Human bone marrow stromal cells were studied for their ability to synthesize and to metabolize platelet-activating factor (PAF), a lipidic compound with potent immunoregulatory properties. When stimulated with 2 microM calcium ionophore for 60 minute
Autor:
F. Glaudet, J.-C. Aldigier
Publikováno v:
Néphrologie & Thérapeutique. 8:269
Publikováno v:
Journal des maladies vasculaires. 19(4)
The association of Ehlers-Danlos type IV syndrome and acrogeria with renovascular hypertension is reported. Ultrastructural abnormalities observed in our case were different of those associated with acrogeria. We propose that acrogeria associated wit
Autor:
D Hillion, J. Godbillon, P Meyer, J.B. Lecaillon, O Kourilsky, P Jungers, M.C. Rouan, F Menard, J C Aldigier, T Darragon
Publikováno v:
European journal of clinical pharmacology. 47(2)
We have studied the effect of renal impairment on the pharmacokinetics of oxcarbazepine, its active monohydroxy-metabolite (which predominates in plasma), their glucuronides, and the inactive dihydroxy-metabolite after a single oral dose of oxcarbaze